The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) received a $1,078,438 Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) to upgrade their genomic sequencing capabilities through the purchase of an Illumina NovaSeq X Plus Sequencing System. This new instrument will enable KUMCRI's Genomics Core to provide enhanced next-generation sequencing services to a broad user base of 25 major and minor investigators with 45 NIH grants, including support for multiple NIH-funded research centers. The award will reduce sequencing costs per gigabase by approximately 59% while improving data quality, ensuring that KUMCRI's sequencing capabilities remain optimal for the foreseeable future. The project will be completed by May 15, 2025.
Generated 1/28/25, 10:58 AM